ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 14

Sec16A Abnormalities Affect the Intracellular Trafficking of HLA-B27 in the Pathogenesis of Axial Spondyloarthritis

Ayantika Talukdar1, Fanxing Zeng 2, Zhenbo Zhang 1 and Nigil Haroon 3, 1University Health Network, Toronto, ON, Canada, 2University Health Network, Toronto, Canada, 3Toronto Western Hospital, Krembil Research Institute, University of Toronto, Toronto, ON, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: axial spondyloarthritis, ER Stress and Next Generation Sequencing, Intracellular trafficking, Sec16A

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Cytokines & Cell Trafficking Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Axial Spondyloarthritis (AxSpA) is a chronic inflammatory arthritis, mainly affecting the axial skeleton. HLA-B27 confers the greatest genetic association in AxSpA. Exome sequencing in a multiplex family had revealed that the incidence of AxSpA in individuals with HLA-B27 and the Sec16A mutation was 100%. Sec16A is a protein that plays a major role in the formation of COPII vesicles and trafficking of proteins from ER to plasma membrane via Golgi Complex. We had previously shown that Sec16A abnormalities not only hinder the assembly of COPII vesicles, leading to abnormal intracellular trafficking and ER stress but also it disrupted the HLA-B27 expression. Here, we aim to investigate whether the Sec16A abnormalities affect the intracellular trafficking of HLA-B27, which is associated with the development of AxSpA, differ from those of HLA-B7, which is not associated. In addition, examining the effect of top 10 interacting proteins of Sec16A, previously identified using BioID, by next generation sequencing help us understanding the pathway associated with intracellular trafficking of HLA-B27.

Methods: Sec16A knockout HeLa cells were generated by transfecting these cells with Sec16A CRISPR/Cas9 KO plasmid (h) and Sec16A HDR plasmid (h) according to manufacturer’s instructions. KO efficiency was determined by western blotting. The plasmids encoding YFP (Yellow Fluorescent Protein) tagged HLA-B27 and HLA-B7 were transfected to HeLa cells and HeLa Sec16A KO cells. The YFP expression of HLA-B7 and HLA-B27 in HeLa cells was assessed by flow cytometry and confocal microscopy at different time points. The real time intracellular trafficking of HLA was monitored using live cell imaging. Also, the expression of properly folded and misfolded HLA-B7 and HLA-B27 were determined using flow cytometry. The top 10 proteins interacting with Sec16A were suppressed using siRNA in C1R-B27 cells and their effect were studied using Next Generation Sequencing.

Results: There was a significant decrease in the expression of both HLA-B7 (p< 0.05) and HLA-B27 (p< 0.05) in the HeLa Sec16A KO cells compared to wild type cells after transfection. HeLa cells showed an intracellular accumulation of HLA-B27 and HLA-B7 as a result of over expression. On the other hand, we did not observe any such vesicle formation in the HeLa Sec16A KO cells. Sec16 KO cells exhibit an exaggerated unfolded protein response resulting in degradation of the HLA-B proteins. This is also evident from the increased level of intracellular misfolded HLA-B27 and HLA-B7 in the Sec16 KO cells. Using next generation sequencing, we found that Sec16A interacting proteins had an effect in the pathways related to inflammation, ER-to-Golgi vesicle mediated transport and antigen presentation.

Conclusion: Sec16A plays a significant role in the trafficking of HLA-B molecules (HLA-B7 and HLA-B27) irrespective of the subtypes, thereby playing a prospective role in the pathogenesis of AxSpA.


Figure 1


Figure 2


Disclosure: A. Talukdar, None; F. Zeng, None; Z. Zhang, None; N. Haroon, Abbive, Amgen, Janssen, Eli Lilly, Novartis AG, UCB Pharma, 5, 8, Abbvie, 5, 8, Amgen, 5, 8, Eli Lilly, 5, 8, Janssen, 5, 8, Merck, 5, 8, Novartis, 5, 8, UCB Pharma, 5, 8.

To cite this abstract in AMA style:

Talukdar A, Zeng F, Zhang Z, Haroon N. Sec16A Abnormalities Affect the Intracellular Trafficking of HLA-B27 in the Pathogenesis of Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/sec16a-abnormalities-affect-the-intracellular-trafficking-of-hla-b27-in-the-pathogenesis-of-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/sec16a-abnormalities-affect-the-intracellular-trafficking-of-hla-b27-in-the-pathogenesis-of-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology